← Eichor
Study identifier: NCT07679451 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Custom-Made PEEK Versus PTFE Membranes in Maxillary Alveolar Ridge Augmentation

Condition: Alveolar Ridge Deficiency  ·  Sponsor: Mansoura University

PhaseNA
Planned participants30
Who can joinAll sexes, 20 Years to 45 Years
Healthy volunteersNo

About this study

This randomized controlled clinical study aims to evaluate and compare the effectiveness of custom-made polyether ether ketone (PEEK) membranes versus polytetrafluoroethylene (PTFE) membranes in guided bone regeneration for maxillary alveolar ridge augmentation in the esthetic zone. Thirty patients requiring ridge augmentation prior to dental implant placement will be enrolled and randomly allocated into two equal groups. Group A will receive customized PEEK membranes, while Group B will be treated with PTFE membranes. Clinical and radiographic assessments, including cone beam computed tomography (CBCT), will be performed immediately postoperatively, at 6 months, and at 12 months to evaluate volumetric, horizontal, and vertical bone gain as well as soft tissue healing and complication rates.

This description comes directly from the study's public registry record.

Talk to the study team

Dania Raad, BDS  ·  00201063498933  ·  raaddania7@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Dania RaadAl Mansurah, Dakhaliya, EgyptRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07679451